Most Undervalued Diagnostics & Research Stocks 2026

Top undervalued Diagnostics & Research stocks in 2026 ranked by Bayesian DCF implied upside. 13-model institutional analysis updated daily.

35 stocks analyzed Updated 2026-05-29
# Ticker Company QOC Price DCF Upside
1 FLGT Fulgent Genetics, Inc. 7.1 $18.24 +240.4%
2 FONR Fonar Corporation 8.3 $19.09 +30.2%
3 IQV IQVIA Holdings, Inc. 8.6 $181.09 +10.5%
4 DHR Danaher Corporation 8.7 $180.63 -5.7%
5 RVTY Revvity, Inc. 8.2 $101.22 -6.0%
6 RDNT RadNet, Inc. 6.2 $55.31 -22.0%
7 LH Labcorp Holdings Inc. 7.6 $262.75 -32.7%
8 CRL Charles River Laboratories Inte 7.8 $181.34 -35.6%
9 BNR Burning Rock Biotech Limited 6.6 $10.10 -39.3%
10 MTD Mettler-Toledo International, I 9.3 $1163.50 -39.4%
11 D••• Quest ••••• •.• $•••.•• ••.•%
12 V••• Veracyte, ••••• •.• $•••.•• ••.•%
13 S••• Sotera ••••• •.• $•••.•• ••.•%
14 A••• Agilent ••••• •.• $•••.•• ••.•%
15 T••• Thermo ••••• •.• $•••.•• ••.•%
16 C••• Castle ••••• •.• $•••.•• ••.•%
17 Q••• Qiagen ••••• •.• $•••.•• ••.•%
18 I••• ICON ••••• •.• $•••.•• ••.•%
19 I••• IDEXX ••••• •.• $•••.•• ••.•%
20 I••• Insight ••••• •.• $•••.•• ••.•%
🔒

Unlock the Full Most Undervalued Diagnostics & Research Stocks 2026 List

Screen all 35 Diagnostics & Research stocks with 13 institutional-grade valuation models. Updated daily from SEC EDGAR filings.

Access Full Screening — From $27/mo →

How CirclFi Ranks Diagnostics & Research Stocks

CirclFi analyzes 35 Diagnostics & Research stocks daily using 13 independent institutional-grade valuation models. Each model processes SEC EDGAR 10-K and 10-Q financial filings (700+ XBRL tags), FRED macroeconomic data, and GDELT news sentiment.

The most undervalued diagnostics & research stocks 2026 ranking uses dcf upside as the primary sort criterion. Models span intrinsic valuation (Bayesian DCF with 10,000 Monte Carlo simulations, EPV), scenario analysis (First Chicago), regime-switching (Markov DDM), and machine learning (ML-RIV, FTNN Topology).